Table 1 Baseline characteristics and gastrointestinal involvement (GI) groups
Baseline characteristics of the patients | ||||
|---|---|---|---|---|
N | 113 | |||
Age, median | 6 (1-15) | |||
(Years) (range) | ||||
SEX (M/F) | 51/62 | |||
Duration from symptom onset to admission (days) (mean ± SD) | 5.8 ± 5.2 | |||
Purpura (%) | 113 (100%) | |||
Arthralgia (%) | 49 (43%) | |||
Abdominal pain (%) | 54 (47%) | |||
GAS infection (%) | 18 (15%) | |||
HSPN (%) | 20 (18%) | |||
Gastrointestinal Involvement Groups | ||||
Group I | Group II | Group II | Group IV | |
N | 57 | 24 | 21 | 11 |
Age, medican | 6 (1-15) | 5.5 (2-13) | 7 (2.-10) | 6 (2-11) |
(Years) (range) | ||||
Duration from symptom onset to admission | 5.8 ± 5.6 | 5.4 ± 4.4 | 5.5 ± 5.5 | 7.5 ± 4.7 |
(Days) (mean ± SD) | ||||
Purpura (%) | 55 (100%) | 23 (100%) | 20 (100%) | 10 (100%) |
Arthralgia (%) | 26 (46%) | 7 (29%) | 11 (52%) | 4 (36%) |
Abdominal pain (%) | - | 23 (100%) | 20 (100%) | 10 (100%) |
GAS infection (%) | 11 (19%) | 3 (13%) | 4 (19%) | 0 (0%) |
PSL administration (%) | 9 (15%) | 15 (63%) | 17 (81%) | 10 (90%) |
HSPN (%) | 5 (9%) | 8 (33%) | 4 (19%) | 3 (27%) |
Significant correlation: HSPN vs Male | (R = 0.35, p = <0.01) | |||